Health
Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants – News-Medical.Net
A new monoclonal antibody targets a particular region of the RBD on the SARS-CoV-2. This region is usually not accessible to immune cells, which may be why it has…
A new monoclonal antibody targets a particular region of the receptor-binding domain (RBD) on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This region is usually not accessible to immune cells, which may be why it has broad neutralizing capabilities.
With the coronavirus disease 2019 (COVID-19) pandemic continuing around the globe, new mutants of SARS-CoV-2 are emerging. These new variants are likely more infectious and can better evade our immune response.
The SARS-CoV-2…
-
Noosa News13 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business15 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
Business16 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
General21 hours agoHopes for peace but pain lingers on Oct 7 anniversary